Frontida BioPharm, Inc.
1100 Orthodox Street
Frontida BioPharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization supporting biopharmaceutical companies in the scale-up and commercial manufacture of immediate and controlled release oral solid dose products. Frontida offers the capability to manufacture Highly Potent Active Ingredient (HPAI) products, Combination Products, as well as DEA schedules II – V products. Its patented Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better engineered and lower production-cost controlled release products.
CEO: Song Li
COO: Ron Connolly
Please click here for Frontida job opportunities.